| 词条 | Brand Institute |
| 释义 |
| name = Brand Institute | logo = | industry = Branding | founded = 1993 | founder = James L. Dettore | locations = 18 offices (2018) | area_served = Worldwide | key_people = {{Unbulleted list|James L. Dettore|William T. Johnson|Ty Marinkov|Todd Bridges}} | services = {{Unbulleted list|Name Development|Trademark Screening|Market Research|Name Safety Research|Linguistic Screening|Visual Identity|Regulatory Services}} | subsid = Drug Safety Institute | website = {{URL|www.brandinstitute.com}} }}Brand Institute is a branding agency that specializes in the development of brand names and identities. The company's primary services include creative name development, trademark screening, market research, regulatory affairs, linguistic analysis, and graphic design (e.g., logos and websites). It is best known for pharmaceutical naming.[1] Brand Institute was founded in 1993 by James (Jim) L. Dettore. Prior to forming Brand Institute, he worked for the multinational corporations PepsiCo, Hilton International Hotels and Ralph Lauren, the advertising agency J. Walter Thompson and the brand consultancy Interbrand. Its first drug naming project was with Wyeth on the anti-obesity drug Redux.[2] In 2004, the company formed the subsidiary, Drug Safety Institute (DSI), which consults the company’s pharmaceutical clients on best practices[3] in drug product naming, packaging, and labeling. Jerry Phillips, the former director of the FDA’s Division of Medication Errors and Technical Support (DMETS), was hired as DSI's president and chief executive officer.[4] Brand Institute’s clients include consumer and business-to-business companies such as AT&T and General Motors, and healthcare companies such as Biogen, Allergan, and Johnson & Johnson. It has named brands such as Lipitor, Clarinex, Sarafem, Allegra, Propecia, Relenza, Climara, Proscar, Invega, Lunesta and Latisse.[1][5][6][7][8] Office Locations{{div col|colwidth=30em}}
References1. ^1 {{Cite news|url=http://www.cnn.com/2016/11/25/health/art-of-drug-naming/index.html|title=The art and science of naming drugs|last=CNN|first=Susan Scutti,|work=CNN|access-date=2018-01-07}} 2. ^{{Cite news|url=http://www.southcoasttoday.com/article/20040427/NEWS/304279949|title=What's in a name? Big business, for a company marketing drugs|last=Newspapers|first=JOHN DORSCHNER, Knight Ridder|work=southcoasttoday.com|access-date=2018-01-07|language=en}} 3. ^{{cite journal | vauthors = Collier R | title = The art and science of naming drugs | journal = CMAJ | volume = 186 | issue = 14 | pages = 1053 | date = October 2014 | pmid = 25200754 | pmc = 4188646 | doi = 10.1503/cmaj.109-4864 }} 4. ^{{Cite news|url=http://www.recordnet.com/article/20040419/a_biz/304199946|title=Naming drugs is big business|last=Herald|first=John Dorschner The Miami|work=recordnet.com|access-date=2018-01-07|language=en}} 5. ^{{Cite news|url=https://www.nytimes.com/2003/12/27/business/the-science-of-naming-drugs-sorry-z-is-already-taken.html|title=The Science of Naming Drugs (Sorry, ’Z’ Is Already Taken)|last=Jr|first=Donald G. McNeil|date=2003-12-27|work=The New York Times|access-date=2018-01-07|language=en-US|issn=0362-4331}} 6. ^{{Cite news|url=https://www.theguardian.com/lifeandstyle/2000/jan/11/healthandwellbeing.health|title=What's got 10 letters, three syllables and costs up to £100,000?|date=2000-01-11|work=The Guardian|access-date=2018-01-07|language=en-GB|issn=0261-3077}} 7. ^{{Cite web|url=http://classic.scopeweb.mit.edu/articles/a-drug-by-any-other-name/|title=MIT {{!}} A Drug by Any Other Name|website=classic.scopeweb.mit.edu|language=en|access-date=2018-01-07}} 8. ^{{Cite news|url=http://www.telegram.com/article/20080120/NEWS/801200655|title=Branding a matter of X, Y, Z|last=PRESS|first=Tom Murphy THE ASSOCIATED|work=telegram.com|access-date=2018-01-07|language=en}} External links
2 : Branding companies of the United States|Companies established in 1993 |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。